MASTERINVEST Kapitalanlage GmbH Purchases Shares of 15,293 Agilent Technologies, Inc. $A

MASTERINVEST Kapitalanlage GmbH acquired a new position in shares of Agilent Technologies, Inc. (NYSE:A) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 15,293 shares of the medical research company’s stock, valued at approximately $1,805,000.

A number of other hedge funds have also modified their holdings of A. Ransom Advisory Ltd purchased a new stake in shares of Agilent Technologies during the first quarter valued at $32,000. Central Pacific Bank Trust Division acquired a new stake in Agilent Technologies during the 2nd quarter worth about $33,000. State of Wyoming purchased a new stake in Agilent Technologies during the second quarter valued at about $35,000. WFA of San Diego LLC purchased a new stake in Agilent Technologies during the second quarter valued at about $61,000. Finally, Ameritas Advisory Services LLC acquired a new position in shares of Agilent Technologies in the second quarter worth about $64,000.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the stock. Citigroup boosted their price target on shares of Agilent Technologies from $165.00 to $185.00 and gave the company a “buy” rating in a report on Tuesday, November 25th. Barclays boosted their target price on shares of Agilent Technologies from $145.00 to $165.00 and gave the company an “equal weight” rating in a research note on Tuesday, November 25th. Rothschild Redb upgraded Agilent Technologies to a “strong-buy” rating in a report on Wednesday, October 8th. Evercore ISI lifted their price target on Agilent Technologies from $128.00 to $140.00 and gave the company an “in-line” rating in a report on Tuesday, October 7th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Agilent Technologies in a research report on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $161.77.

Agilent Technologies Trading Down 2.3%

Shares of NYSE:A opened at $139.56 on Friday. The firm has a fifty day moving average of $145.59 and a two-hundred day moving average of $129.15. The company has a quick ratio of 1.52, a current ratio of 1.96 and a debt-to-equity ratio of 0.45. Agilent Technologies, Inc. has a 12-month low of $96.43 and a 12-month high of $160.27. The firm has a market capitalization of $39.57 billion, a P/E ratio of 30.54, a price-to-earnings-growth ratio of 4.05 and a beta of 1.27.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Monday, November 24th. The medical research company reported $1.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.58 by $0.01. The business had revenue of $1.86 billion during the quarter, compared to analyst estimates of $1.83 billion. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.Agilent Technologies’s quarterly revenue was up 9.4% compared to the same quarter last year. During the same period last year, the company earned $1.46 earnings per share. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. On average, equities analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 28th. Stockholders of record on Tuesday, January 6th will be issued a dividend of $0.255 per share. The ex-dividend date is Tuesday, January 6th. This represents a $1.02 annualized dividend and a dividend yield of 0.7%. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.25. Agilent Technologies’s dividend payout ratio is presently 21.66%.

Insider Activity

In related news, CEO Padraig Mcdonnell sold 911 shares of the business’s stock in a transaction that occurred on Tuesday, November 18th. The stock was sold at an average price of $143.24, for a total value of $130,491.64. Following the completion of the sale, the chief executive officer owned 32,058 shares of the company’s stock, valued at approximately $4,591,987.92. The trade was a 2.76% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, VP Rodney Gonsalves sold 3,000 shares of the stock in a transaction that occurred on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total value of $464,970.00. Following the completion of the transaction, the vice president owned 31,846 shares in the company, valued at $4,935,811.54. This represents a 8.61% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 16,401 shares of company stock valued at $2,468,962.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.